HER2,

Yanjun Hou1, Hiroaki Nitta2, Zaibo Li3

  • 1Department of Pathology and Laboratory Medicine, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC 28659, USA.

Cancers
|June 22, 2023
PubMed
概括

乳腺癌中的人体表皮生长因子受体2 (HER2) 内异质性 (ITH) 与不良结果和对抗HER2疗法的耐药性有关. 需要进一步的研究来澄清HER2 ITH.